Publications by authors named "F Cappuccini"

Claim this Profile
M
MYBPC3 c.2309-2A>G: exploring a founder variant in Italian hypertrophic cardiomyopathy patients.
Marco Fabiani, Caterina Micolonghi, Silvia Caroselli, Camilla Savio, Simona Petrucci, Francesca Cappuccini

Eur J Hum Genet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil.
Sue Ann Costa Clemens, Sagida Bibi, Natalie G Marchevsky, Parvinder K Aley, Federica Cappuccini

Mayo Clin Proc Innov Qual Outcomes· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006).
Grace Li, Natalie G Marchevsky, Grace Macaulay, Parvinder Aley, Hannah Baughan, Federica Cappuccini

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.
Shuo Feng, Sagida Bibi, Parvinder K Aley, Federica Cappuccini, Elizabeth A Clutterbuck

J Infect· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Merryn Voysey, Amy Flaxman, Jeremy Aboagye, Parvinder K Aley, Sandra Belij-Rammerstorfer, Federica Cappuccini

Clin Exp Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis